The NPA has issued a brief guide to the EU Falsified Medicines Directive, in the light of growing concerns about a lack of publicly available information from official channels.  The Directive, which has been introduced to reduce the risk of counterfeit medicines in the supply chain, comes into force on 9 February 2019.

Raj Patel, NPA Board Member said: “As it stands, we are still awaiting crucial details from government about the final shape of FMD.  We also need guidance about the position post-Brexit and assurances on funding. 

"This means that the pharmacy sector can’t yet make major investment decisions in relation to FMD.  In turn, this makes a February 2019 implementation date challenging, to say the least.  Unless the government fills the information gap soon, a challenging deadline will become an impossible deadline.”    

To view the guide click here.